Skip navigation.
Home

archives

Neurocrine Announces Peer-Reviewed Publication of Indiplon ...

... Neurocrine Announces Peer-Reviewed Publication of Indiplon Mechanism of Action

Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content.

Terms ...

Pharmos Sets Strategic Priorities for Development of Vela ...

... Pharmos Sets Strategic Priorities for Development of Vela Compounds: Financial News - Yahoo! Finance

Pharmos Sets Strategic Priorities for Development of Vela Compounds

Copyright 2006 Yah ...

Marinova seeks nutraceutical partners for fucoidans

... ...

Herbal Therapy (CHT) Versus Placebo in Patients With Irritable ...

... irritable bowel syndrome, relative to placebo

Secondary Outcomes: 30% change on the IBS-36 from baseline to 4 weeks (“no” or “yes”); Change on IBS-36 from 4 weeks (last treatment taken) and 8 we ...